|
1
|
Antoni S, Ferlay J, Soerjomataram I, Znaor
A, Jemal A and Bray F: Bladder cancer incidence and mortality: A
global overview and recent trends. Eur Urol. 71:96–108. 2017.
View Article : Google Scholar
|
|
2
|
Cumberbatch MGK, Jubber I, Black PC,
Esperto F, Figueroa JD, Kamat AM, Kiemeney L, Lotan Y, Pang K,
Silverman DT, et al: Epidemiology of bladder cancer: A systematic
review and contemporary update of risk factors in 2018. Eur Urol.
74:784–795. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kamat AM, Hahn NM, Efstathiou JA, Lerner
SP, Malmström PU, Choi W, Guo CC, Lotan Y and Kassouf W: Bladder
cancer. Lancet. 388:2796–2810. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Soukup V, Čapoun O, Cohen D, Hernández V,
Babjuk M, Burger M, Compérat E, Gontero P, Lam T, MacLennan S, et
al: Prognostic performance and reproducibility of the 1973 and
2004/2016 world health organization grading classification systems
in non-muscle-invasive bladder cancer: A European association of
urology non-muscle invasive bladder cancer guidelines panel
systematic review. Eur Urol. 72:801–813. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Funt SA and Rosenberg JE: Systemic,
perioperative management of muscle-invasive bladder cancer and
future horizons. Nat Rev Clin Oncol. 14:221–234. 2017. View Article : Google Scholar
|
|
6
|
Sargos P, Baumann BC, Eapen L,
Christodouleas J, Bahl A, Murthy V, Efstathiou J, Fonteyne V,
Ballas L, Zaghloul M, et al: Risk factors for loco-regional
recurrence after radical cystectomy of muscle-invasive bladder
cancer: A systematic-review and framework for adjuvant
radiotherapy. Cancer Treat Rev. 70:88–97. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer. J Clin. 66:115–132. 2016.
|
|
8
|
Vicens Q and Westhof E: Biogenesis of
circular RNAs. Cell. 159:13–14. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jeck WR and Sharpless NE: Detecting and
characterizing circular RNAs. Nat Biotechnol. 32:453–461. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li X, Yang L and Chen LL: The biogenesis,
functions, and challenges of circular RNAs. Mol Cell. 71:428–442.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Holdt LM, Stahringer A, Sass K, Pichler G,
Kulak NA, Wilfert W, Kohlmaier A, Herbst A, Northoff BH, Nicolaou
A, et al: Circular non-coding RNA ANRIL modulates ribosomal RNA
maturation and atherosclerosis in humans. Nat Commun. 7:124292016.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen F, Chen X, Yang D, Che X, Wang J, Li
X, Zhang Z, Wang Q, Zheng W, Wang L, et al: Isoquercitrin inhibits
bladder cancer progression in vivo and in vitro by regulating the
PI3K/Akt and PKC signaling pathways. Oncol Rep. 36:165–172. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hansen TB, Jensen TI, Clausen BH, Bramsen
JB, Finsen B, Damgaard CK and Kjems J: Natural RNA circles function
as efficient microRNA sponges. Nature. 495:384–388. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Han D, Li J, Wang H, Su X, Hou J, Gu Y,
Qian C, Lin Y, Liu X, Huang M, et al: Circular RNA circMTO1 acts as
the sponge of microRNA-9 to suppress hepatocellular carcinoma
progression. Hepatology. 66:1151–1164. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yu J, Xu QG, Wang ZG, Yang Y, Zhang L, Ma
JZ, Sun SH, Yang F and Zhou WP: Circular RNA cSMARCA5 inhibits
growth and metastasis in hepatocellular carcinoma. J Hepatol.
68:1214–1227. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen X, Chen RX, Wei WS, Li YH, Feng ZH,
Tan L, Chen JW, Yuan GJ, Chen SL, Guo SJ, et al: PRMT5 circular RNA
promotes metastasis of urothelial carcinoma of the bladder through
sponging miR-30c to induce epithelial-mesenchymal transition. Clin
Cancer Res. 24:6319–6330. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen Y, Yang F, Fang E, Xiao W, Mei H, Li
H, Li D, Song H, Wang J, Hong M, et al: Circular RNA circAGO2
drives cancer progression through facilitating HuR-repressed
functions of AGO2-miRNA complexes. Cell Death Differ. 26:1346–1364.
2019. View Article : Google Scholar
|
|
18
|
Weng W, Wei Q, Toden S, Yoshida K,
Nagasaka T, Fujiwara T, Cai S, Qin H, Ma Y and Goel A: Circular RNA
ciRS-7-A promising prognostic biomarker and a potential therapeutic
target in colorectal cancer. Clin Cancer Res. 23:3918–3928. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Memczak S, Jens M, Elefsinioti A, Torti F,
Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH and
Munschauer M: et al: Circular RNAs are a large class of animal RNAs
with regulatory potency. Nature. 495:333–338. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu S, Li X, Lin Z, Su L, Yan S, Zhao B
and Miao J: SEC-induced activation of ANXA7 GTPase suppresses
prostate cancer metastasis. Cancer Lett. 416:11–23. 2018.
View Article : Google Scholar :
|
|
21
|
Li Y, Zheng F, Xiao X, Xie F, Tao D, Huang
C, Liu D, Wang M, Wang L, Zeng F and Jiang G: CircHIPK3 sponges
miR-558 to suppress heparanase expression in bladder cancer cells.
EMBO Rep. 18:1646–1659. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li M, Liu Y, Zhang X, Liu J and Wang P:
Transcriptomic analysis of high-throughput sequencing about
circRNA, lncRNA and mRNA in bladder cancer. Gene. 677:189–197.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Eke I and Cordes N: Focal adhesion
signaling and therapy resistance in cancer. Semin Cancer Biol.
31:65–75. 2015. View Article : Google Scholar
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
25
|
Yu G, Wang LG, Han Y and He QY:
clusterProfiler: An R package for comparing biological themes among
gene clusters. OMICS. 16:284–287. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chou CH, Shrestha S, Yang CD, Chang NW,
Lin YL, Liao KW, Huang WC, Sun TH, Tu SJ, Lee WH, et al: miRTarBase
update 2018: A resource for experimentally validated
microRNA-target interactions. Nucleic Acids Res. 46(D1): pp.
D296–D302. 2018, View Article : Google Scholar :
|
|
27
|
Yao Y, Chen X, Yang H, Chen W, Qian Y, Yan
Z, Liao T, Yao W, Wu W, Yu T, et al: Hsa_circ_0058124 promotes
papillary thyroid cancer tumorigenesis and invasiveness through the
NOTCH3/GATAD2A axis. J Exp Clin Cancer Res. 38:3182019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wu K, Liao X, Gong Y, He J, Zhou JK, Tan
S, Pu W, Huang C, Wei YQ and Peng Y: Circular RNA F-circSR derived
from SLC34A2-ROS1 fusion gene promotes cell migration in non-small
cell lung cancer. Mol Cancer. 18:982019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang L, Long H, Zheng Q, Bo X, Xiao X and
Li B: Circular RNA circRHOT1 promotes hepatocellular carcinoma
progression by initiation of NR2F6 expression. Mol Cancer.
18:1192019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Soonthornvacharin S, Rodriguez-Frandsen A,
Zhou Y, Galvez F, Huffmaster NJ, Tripathi S, Balasubramaniam VR,
Inoue A, de Castro E, Moulton H, et al: Systems-based analysis of
RIG-I-dependent signalling identifies KHSRP as an inhibitor of
RIG-I receptor activation. Nat Microbiol. 2:170222017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kristensen LS, Hansen TB, Veno MT and
Kjems J: Circular RNAs in cancer: Opportunities and challenges in
the field. Oncogene. 37:555–565. 2018. View Article : Google Scholar :
|
|
32
|
Liang WC, Wong CW, Liang PP, Shi M, Cao Y,
Rao ST, Tsui SK, Waye MM, Zhang Q, Fu WM and Zhang JF: Translation
of the circular RNA circβ-catenin promotes liver cancer cell growth
through activation of the Wnt pathway. Genome Biol. 20:842019.
View Article : Google Scholar
|
|
33
|
Braicu C, Zimta AA, Gulei D, Olariu A and
Berindan-Neagoe I: Comprehensive analysis of circular RNAs in
pathological states: Biogenesis, cellular regulation, and
therapeutic relevance. Cell Mol Life Sci. 76:1559–1577. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Vo JN, Cieslik M, Zhang Y, Shukla S, Xiao
L, Zhang Y, Wu YM, Dhanasekaran SM, et al: The landscape of
circular RNA in cancer. Cell. 176:869–881.e13. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xie F, Li Y, Wang M, Huang C, Tao D, Zheng
F, Zhang H, Zeng F, Xiao X and Jiang G: Circular RNA BCRC-3
suppresses bladder cancer proliferation through miR-182-5p/p27
axis. Mol Cancer. 17:1442018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xu ZQ, Yang MG, Liu HJ and Su CQ: Circular
RNA hsa_ circ_0003221 (circPTK2) promotes the proliferation and
migration of bladder cancer cells. J Cell Biochem. 119:3317–3325.
2018. View Article : Google Scholar
|
|
37
|
Song C, Li D, Liu H, Sun H, Liu Z, Zhang L
and Hu Y: The competing endogenous circular RNA ADAMTS14 suppressed
hepatocellular carcinoma progression through regulating
microRNA-572/regulator of calcineurin 1. J Cell Physiol.
234:2460–2470. 2019. View Article : Google Scholar
|
|
38
|
Subramani D and Alahari SK:
Integrin-mediated function of Rab GTPases in cancer progression.
Mol Cancer. 9:3122010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Peng JM, Bera R, Chiou CY, Yu MC, Chen TC,
Chen CW, Wang TR, Chiang WL, Chai SP and Wei Y: et al: Actin
cytoskeleton remodeling drives epithelial-mesenchymal transition
for hepatoma invasion and metastasis in mice. Hepatology.
67:2226–2243. 2018. View Article : Google Scholar
|
|
40
|
Ohishi T, Yoshida H, Katori M, Migita T,
Muramatsu Y, Miyake M, Ishikawa Y, Saiura A, Iemura SI, Natsume T
and Seimiya H: Tankyrase-binding protein TNKS1BP1 regulates actin
cytoskeleton rearrangement and cancer cell invasion. Cancer Res.
77:2328–2338. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Schlienger S, Ramirez RA and Claing A:
ARF1 regulates adhesion of MDA-MB-231 invasive breast cancer cells
through formation of focal adhesions. Cell Signal. 27:403–415.
2015. View Article : Google Scholar
|
|
42
|
Meng F, Saxena S, Liu Y, Joshi B, Wong TH,
Shankar J, Foster LJ, Bernatchez P and Nabi IR: The
phospho-caveolin-1 scaffolding domain dampens force fluctuations in
focal adhesions and promotes cancer cell migration. Mol Biol Cell.
28:2190–2201. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Petry IB, Fieber E, Schmidt M, Gehrmann M,
Gebhard S, Hermes M, Schormann W, Selinski S, Freis E and Schwender
H: et al: ERBB2 induces an antiapoptotic expression pattern of
Bcl-2 family members in node-negative breast cancer. Clin Cancer
Res. 16:451–460. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Junttila TT, Laato M, Vahlberg T,
Söderström KO, Visakorpi T, Isola J and Elenius K: Identification
of patients with transitional cell carcinoma of the bladder
overexpressing ErbB2, ErbB3, or specific ErbB4 isoforms: Real-time
reverse transcription-PCR analysis in estimation of ErbB receptor
status from cancer patients. Clin Cancer Res. 9:5346–5357.
2003.PubMed/NCBI
|
|
45
|
Groenendijk FH, de Jong J, Fransen van de
Putte EE, Michaut M, Schlicker A, Peters D, Velds A, Nieuwland M,
van den Heuvel MM, Kerkhoven RM, et al: ERBB2 mutations
characterize a subgroup of muscle-invasive bladder cancers with
excellent response to neoadjuvant chemotherapy. Eur Urol.
69:384–388. 2016. View Article : Google Scholar
|
|
46
|
Liu G, Huang K, Jie Z, Wu Y, Chen J, Chen
Z, Fang X and Shen S: CircFAT1 sponges miR-375 to promote the
expression of Yes-associated protein 1 in osteosarcoma cells. Mol
Cancer. 17:1702018. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zhang J, Zhang J, Qiu W, Zhang J, Li Y,
Kong E, Lu A, Xu J and Lu X: MicroRNA-1231 exerts a tumor
suppressor role through regulating the EGFR/PI3K/AKT axis in
glioma. J Neurooncol. 139:547–562. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Zhou C, Yu Q, Chen L, Wang J, Zheng S and
Zhang J: A miR-1231 binding site polymorphism in the 3′UTR of
IFNAR1 is associated with hepatocellular carcinoma susceptibility.
Gene. 507:95–98. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Mao XP, Zhang LS, Huang B, Zhou SY, Liao
J, Chen LW, Qiu SP and Chen JX: Mir-135a enhances cellular
proliferation through post-transcriptionally regulating PHLPP2 and
FOXO1 in human bladder cancer. J Transl Med. 13:862015. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Huang C, Liao X, Jin H, Xie F, Zheng F, Li
J, Zhou C, Jiang G, Wu XR and Huang C: MEG3, as a competing
endogenous RNA, binds with miR-27a to promote PHLPP2 protein
translation and impairs bladder cancer invasion. Mol Ther Nucleic
Acids. 16:51–62. 2019. View Article : Google Scholar : PubMed/NCBI
|
